Chapter 5
Endnotes for Arthritis and Autoimmune Disease: The Infection Connection
Emerging Epidemics
1) Vergano, Dan. “Bacteria Tied to Chronic Illnesses.” Medical Sentinel (1999;4:172-6).
2) http://labtestsonline.org/understanding/analytes/anca/tab/test
3)
See www.thearthritiscenter.com for details.
4)
Unattributed article. “Antibiotic Provides Significant Improvement
in Early Rheumatoid Arthritis.” Online at http://www.pslgroup.com/dg/44866.htm
5)
A chart showing co-infections and symptoms is found at www.lyme-symptoms.com/LymeCoinfectionChart.html
(2010)
6)
Long, Pickering, and Prober (2008)
7)
For an excellent overview, see www.medicinenet.com/rocky_mountain_spotted_fever/article.htm
8)
www.cdc.gov/rmsf/stats/index.html
9)
Zimmerman and Zimmerman (1996), pp.97-98.
10) Chen, M., et al. “Antibiotics to Treat Huntington’s Disease.” Nature Medicine
2000;6:797–801.
11) www.best-of-cape-cod.com/lyme-disease-on-cape-cod.html
12)
[1]See www.lymenet.org
for more information on Lyme disease, and www.ped-onc.org/WebInfo/journalsearchinfo.html
for a collection of medical journal abstracts. The website of the International
Lyme and Associated Diseases Society (ILADS) is found at www.ilads.org.
13) Nicolson, GL.
“Diagnosis and Therapy of Chronic Systemic Co-infections in Lyme Disease and
Other Tick-Borne Infectious Diseases.” Lyme Disease Diagnosis & Therapy
Suggestions 2006 ACAM Meeting
14) Nicolson GL,
Nicolson NL, Haier J. “CFS Patients Subsequently Diagnosed with Lyme Disease Borrelia
burgdorferi: Evidence for Mycoplasma species Co-Infections.” Journal of
Chronic Fatigue Syndrome 2008; 14(4): 5-17.
15) Check www.heathmap.org
to find locations of recent outbreaks.
16) http://www.cdc.gov/ncidod/dvbid/westnile/qa/wnv_horses.htm
17) Sodium Ascorbate
can be administered by IV, by injection, or orally every 2 hours, like a drug.
See http://www.orthomed.com/Nile.htm
(2003)
18) Forsgren, Scott.
“Mycoplasma—Often Overlooked in Chronic Lyme Disease.” Public Health Alert,
v. 4, no. 7, 2009
19) http://www.lyme-symptoms.com/CoInfections.html
(2010)
20) See www.cdc.gov/ticks/life_cycle_and_hosts.html
21) See www.cdc.gov/ncidod/eid/vol7no5/bjoersdorff.htm
for details of a CDC study examining the role of migrating birds as benevolent
hosts to Ehrlichia-infected ticks.
22) www.aldf.com/deerTickEcology.shtml
23) MacQueen DD, et
al. “Genotypic Diversity of an Emergent Population of Borrelia burgdorferi at a
Coastal Maine Island Recently Colonized by Ixodes scapularis.” Vector Borne
Zoonotic Dis. Vol 12, No. XX, 2012. Online at http://www.ncbi.nlm.nih.gov/pubmed/22217172?dopt=Abstract
24) International
Lyme and Associated Diseases Society (ILADS) Position Paper on the CDC’S
Statement Regarding Lyme Diagnosis. Full text at www.ilads.org/about_ILADS/position_papers3.html
25) Burrascano, Jr.,
Dr. J.J. “Advanced Topics in Lyme Disease.” 16th ed. At
www.lymenet.org/BurrGuide200810.pdf. October 2008. This is an excellent,
comprehensive overview that is continually revised as new information is
obtained.
26) www.medicinenet.com/ticks/article.htm.
27) Bransfield, Dr.
Robert. “The Neuropsychiatric Assessment of Lyme Disease.” Go to www.mentalhealthandillness.com
and use the search window to find this and many more articles.
28) Steere, AC, et
al. “The emergence of Lyme disease.” J Clin Invest.
2004;113(8):1093–1101. Online at http://www.jci.org/articles/view/21681
29) www.lyme.org/resources.html
30) Some of these
laboratories are: www.labodia.com,
www.spirostat.com/organisms/index.php,
www.rightdiagnosis.com/e/ehrlichiosis/tests.htm
31) [1]Klempner MS, et
al. Intralaboratory reliability of serologic and urine testing for Lyme
disease. American Journal of Medicine 110:217-219.
32) Discussion with
Dr. Garth Nicolson, March 2012. IGeneX Laboratories is located in Palo Alto, CA
(http://www.igenex.com/
).
33) Statements in
this chapter attributed to Dr. Burrascano are based on his presentations in
Seattle at the 2011 International IFM conference on infectious diseases of the
21st Century.
34) Autoimmunity
Research Foundation’s “Recovering from Chronic Disease” Conference comment,
March 2005.
35) Find a wealth of
information at www.lymeinfo.net/lymediseasetreatment.html
36) www.lymeinfo.net/pain.html
37) http://columbia-lyme.org/patients/controversies.html
38) Find more detail
at www.lymebook.com/top10forms
39) Burrascano,
“Advanced Topics in Lyme Disease.” Online at www.ilads.org/files/burrascano_0905.pdf (2005)
40) www.ilads.org/files/burrascano_0905.pdf
discusses advanced topics in Lyme disease.
41) www.cdc.gov/lyme
42) http://lymediseaseresourcec.bizland.com/archives/LT23.PDF
(1998)
43) [1]Op cit, Burrascano.
Find details of opportunistic infections (bacteria and viruses) at www.ilads.org/files/burrascano_0905.pdf (2005)
44) Examples are www.LymeInfo.net, www.LymeNet.org,
www.ILADS.org, www.LymeAlliance.org, http://LymeMD.blogspot.com,
www.Lyme.org
and www.turnthecorner.org.
45) A good place to
start for multi-antibiotic protocol against LD is http://bacteriality.com/about-the-mp/ (2009) and www.marshallprotocol.com/
46) Shoemaker
(2001).
47) Dr. Shoemaker’s
approach to LD is described in detail at www.chronicneurotoxins.com.
48) http://www.ra-infection-connection.com/coq10andstatins.htm
49) http://emedicine.medscape.com/article/395381-overview
(2011)
50) Reported
Tuberculosis in the United States, 2009. Executive Commentary.” Online at www.cdc.gov .
51) www.nyc.gov/html/doh/downloads/pdf/tb/tb-control-kambili.pdf
(2010)
52) More information
with references at www.drmirkin.com/morehealth/G115.htm and www.drmirkin.com/morehealth/G144.htm (both checked 2011)
53) Jerome Groopman,
M.D., Annals of Medicine, “Hurting All Over,” The New Yorker,
November 13, 2000, p. 78. Online at http://www.newyorker.com/archive/2000/11/13/2000_11_13_078_TNY_LIBRY_000022064
54) http://www.chronicneurotoxins.com/learnmore/fibromyalgia.cfm.
Also see Shoemaker (2001 and 2005)
55) Endresen GK.
“Mycoplasma blood infection in chronic fatigue and fibromyalgia syndromes.” Rheumatol
Int. 2003 Sep;23(5):211-5. Online at www.ncbi.nlm.nih.gov/pubmed/12879275
56) An excellent
overview of Mycoplasma with many scientific references to its role in CFIDS,
FMS, RA, and other chronic, fatiguing illnesses can be found at www.rain-tree.com/mycoresearch.htm
57) http://health.nytimes.com/health/guides/disease/hypothyroidism-secondary/symptoms.html
(2008)
58) “Evidence of
neuroendocrine system dysfunction in Fibromyalgia.” Online at www.rain-tree.com/fibromyalgia.htm
59) Rebecca C.
Moore. “Neurally Mediated Hypotension and CFS: An Interview with Johns Hopkins
University's Dr. Peter Rowe.” Online at http://www.cfids.org/youth/articles/medical/rowe95.asp.
Originally published in Youth Allied By CFIDS, Fall 1995. (Includes 7
supportive references).
60) Bou-Holaigah I,
et al. “Provocation of Hypotension and Pain During Upright Tilt Table Testing
in Adults with Fibromyalgia.” Clinical and Experimental Rheumatology
15:239-246, 1997. Online at www.nfra.net/LowBld_2.htm
61) Mayo Clinic
Staff. “Low blood pressure (hypotension): Treatments and drugs.” Online at http://www.mayoclinic.com/health/low-blood-pressure/DS00590/DSECTION=treatments-and-drugs.
(2011) Another interesting treatment that does not cure FMS but brings some
relief is a method called “FibroFix” developed by Fibromyalgia sufferer Anne
Hillebrand. She manages a nonprofit discussion group at http://health.groups.yahoo.com/group/FibroFix-Forum/
Find details and ratings of
this method and others at http://www.fibromyalgia-reviews.com/
62) See a free
online video of an Autism Research Institute 2011 presentation “Autism as a
Multisystem, Whole-Body Disorder” at http://www.ariconference.com
63) MMWR Surveill
Summ. 2009 Dec 18;58(10):1-20.[45 collaborators]. “Prevalence of
autism spectrum disorders - Autism and Developmental Disabilities Monitoring
Network, United States, 2006.” Online at www.cdc.gov/mmwr/preview/mmwrhtml/ss5810a1.htm
64) Jon Baio, EdS,
National Center on Birth Defects and Developmental Disabilities. CDC.
“Prevalence of Autism Spectrum Disorders — Autism and Developmental
Disabilities Monitoring Network, 14 Sites, United States, 2008.” Centers for
Disease Control’s Morbidity and Mortality Weekly Report (MMWR). Surveillance Summaries, March 30, 2012 /
61(SS03);1-19. Online at http://www.cdc.gov/mmwr/preview/mmwrhtml/ss6103a1.htm?s_cid=ss6103a1_w
65) American Academy
of Pediatrics http://www.tacanow.org/family-resources/latest-autism-statistics-2/
(2011)
66) www.autism.net.au/Autism_causes.htm
and http://psychology.uwo.ca/autism.htm
67) www.cdc.gov/ncbddd/autism/data.html
68) www.researchautism.net/interventionitem.ikml?print&ra=67&infolevel=4
69) Rossignal DA,
Rossignol LW. “Hyperbaric oxygen therapy may improve symptoms in autistic
children.” Medical Hypotheses (2006) http://sirricenter.com/pdfs/HBOT_autism.pdf
70) Rossignal DA,
Rossignol LW, et al. “Hyperbaric treatment for children with autism: a multicenter,
randomized, double-blind, controlled trial.” BMC
Pediatrics 2009, 9:21. Online at www.biomedcentral.com/1471-2431/9/21
71) Besides Dr.
Nicolson’s considerable research at www.immed.org, also see www.ageofautism.com/2011/04/the-potential-importance-of-the-xmrv-retrovirus-to-autism.html
72) Nicolson GL, Gan
R, Nicolson NL, Haier J. “Evidence for Mycoplasma ssp., Chlamydia pneunomiae,
and human herpes virus-6 coinfections in the blood of patients with autistic
spectrum disorders.” J Neurosci Res. 2007 Apr;85(5):1143-8.
73) www.whale.to/y/autism_vitA.html
(1999)
74) Cannell JJ. “On
the aetiology of autism.” Acta Pædiatrica 2010 99, pp. 1128–1130. Also
Levenson CW, Figueiroa SM. “Gestational vitamin D deficiency: long-term effects
on the brain.” Nutr Rev 2008; 66:726–9.
75) http://drclark.typepad.com/dr_david_clark/2010/06/new-research-autism-vitamin-deficiency-.html (2010)
76) Annweiler C,
Schott AM, et al. “Association of vitamin D deficiency with cognitive
impairment in older women: cross-sectional study.” Neurology. 2010 Jan
5;74(1):27-32.
77) Knekt P, Kilkkinen A, et al. “Serum Vitamin D and
the Risk of Parkinson Disease.” Arch Neurol. 2010;67(7):808-811
78) http://autism-nutrition.com/vitamin-b12-autism (2011)
79) www.psychology.uwo.ca/autism/index.htm
80) Parracho M, et
al. “Differences between the gut microflora of children with autistic spectrum
disorders and that of healthy children.” J. Med. Microbiol. 54, 987-991
(2005)
81) http://pptu.lefora.com/2010/12/01/pptu-autism-asd/.
Study done by Metametrix.
82) Valicenti-McDermott
M, et al. “Frequency of gastrointestinal symptoms in children with autistic
spectrum disorders and association with family history of autoimmune
disease.” J. Dev. Behav. Pediatr.
27, S128-36 (2006)
83) Frigsman A, et
al. “Clinical Presentation and Histologic Findings at Ileocolonoscopy in
Children with Autistic Spectrum Disorder and Chronic Gastrointestinal
Symptoms.” Autism Insights 2010:2 1-11. Online at www.la-press.com/clinical-presentation-and-histologic-findings-at-ileocolonoscopy-in-ch-article-a1816
84) Diaz Heijtz R,
et al. “Normal gut microbiota modulates brain development and behavior.” Proc.
Natl. Acad. Sci. (2011)
85) Unattributed,
from the Behavioural Neurothrapy Clinic, Doncaster, Victoria, Australia.
“Cellular malnutrition and Intestinal Dysbiosis in Autism.” Online at www.adhd.com.au/Intestinal_Dysbiosis.htm
(2010)
86) Fasano, Dr.
Alessio. Presentation at April 2010 DAN! Conference in Baltimore, MD.
“Intestine, Leaky Gut, and Autism: A Serendipitous Association of a Planned
Design?”
87) Vojdani A, “A
Gut Feeling for Immune Dysregulation & Neuroinfalmmation in Autrism”
(2008). Online at http://www.immunoscienceslab.com/Articles/A%20Gut%20Feeling%20US.pdf
88) www.eastvalleynd.com/specialty-labs/igg-food-intolerance-testing-.html
89) www.newautism.com/new-study-claims-vaccines-are-safe-is-it-true/1293/
90) See collected
research at http://www.ra-infection-connection.com/KalokerinosAA-VaccinesRefs.htm
91) “Autism and
Vaccines Around the World: Vaccine Schedules, Autism Rates, and Under 5
Mortality”. Special Report by Generation Rescue, Inc. April 2009. Online at http://www.rescuepost.com/files/gr-autism_and_vaccines_world_special_report1.pdf
92) http://www.hhs.gov/news/press/2011pres/02/20110216b.html
93) Graham M,
Edwards MJ. “Teratogen Update: Gestational Effects of Maternal Hyperthermia Due
to Febrile Illnesses and Resultant Patterns of Defects in Humans.” Teratology
58: 209–21. 1998.
94) Conversation
with Dr. Hawkins Kirk, February, 2011.
95) www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm089001.htm
96) www.inchem.org/documents/ehc/ehc/ehc22.htm
(1982)
97) Hynynen K, et
al. “Potential adverse effects of high-intensity focused ultrasound exposure on
blood vessels in vivo.” Online at www.sciencedirect.com/science/article/pii/0301562995020446
98) www.centrus.com.br/DiplomaFMF/SeriesFMF/doppler/capitulos-html/chapter_02.htm
(2002) and also www.fetalultrasoundsafety.net
99) www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PatientAlerts/ucm064756.htm
100) Rados, Carol.
2004. FDA Cautions Against Ultrasound "Keepsake" Images. FDA Consumer
Magazine. Online at www.fda.gov/fdac/features/2004/104_images.html
101) Barnard, J, et
al. "Autism in schools: Crisis or challenge?" The National Autistic
Society. Full report online at http://www.autism.org.uk/~/media/nas/documents/about-autism/autism-library/magazines-articles-and-reports/reports/our-reports/autism%20in%20schools%20%20crisis%20or%20challenge%20full%20report.ashx
102) John Stone. “UK
Government Farce Over New Adult Autism Study.” http://www.ageofautism.com/2009/09/uk-government-farce-over-new-adult-autism-study-.html.
Coverups appear to be worldwide. See collected research at http://www.ra-infection-connection.com/KalokerinosAA-VaccinesRefs.htm
103) “Autism: The
Grand Cause 2012.” Online at www.autismegrandecause2012.fr/
104) www.midwiferytoday.com/articles/ultrasoundrodgers.asp
105) Excellent
examples are www.Autism360.org
and www.AutismSpeaks.org . Case studies and therapy information can
be found at www.AutismFile.com
106) “Basic
pathogenetic considerations.” In: Espinoza LR, et al. (1988) pp. 125-9. Also
see “Leaky Gut Syndromes: Breaking the Vicious Cycle” by Dr. Leo Galland, M.D.
Online at http://mdheal.org/leakygut.htm
107) Conversation
with Dr. Marge Crandall, microbiologist specializing in Candida and owner of www.yeastconsulting.com/index.html.
Testing and diagnosis services are provided, along with physician referrals.
108) Saliva test kits
sold by Bio Health Diagnostics, www.biodia.com
109) See www.betterhealthusa.com/public/156.cfm.
They offer a physician referral network at www.betterhealthusa.com/public/department45.cfm
and articles linking specific conditions (e.g., autism) with food allergies.
See www.betterhealthusa.com/public/department32.cfm
110) http://entmd.org/HealthInformation/sinuses.cfm
111) Sherris D, et
al. “Mayo Clinic Study Implicates Fungus as Cause of Chronic Sinusitis.” Mayo
Clinic Proceedings, September 1999.
112) Dr. Joseph
Mercola, comparing unnecessary sinus surgery to routine gallbladder removal as
“another major tragedy in medicine.” For proposed alternatives to sinus surgery
see www.mercola.com.
113) http://advancedmoldinspections.com/types_of_mold.html
114) www.pasteurlaboratory.com/common1.htm
115) www.mycotoxins.info/myco_info/qanda.html
116) http://www.survivingmold.com/treatment
117) www.oasisadvancedwellness.com/learning/fungus-sinus.html
118) “Rare,
Aggressive Fungus Strikes Joplin Tornado Victims.” KMOX/AP, June 10, 2011.
Unattributed feature.
119) When aerosolized
they have the potential for use as biological warfare toxins of the type called
“yellow rain” allegedly used during the late 1970s in Laos, Kampuchea, and
Afghanistan.
120) Sherris, et al. Mayo Clinic Proceedings (1999).
121) Shoemaker (2010)
122) http://www.chronicneurotoxins.com
and Shoemaker (2001 and 2005)
123) http://www.irmi.com/expert/articles/2004/zalma08.aspx
124) Dr. Omar M.
Amin. “Understanding Parasites” Parasitology Center, Scottsdale, AZ. (2010).
125) “UFOs of the
Intestines.” (review) J. Rheum. 1998, 25 (11) 2181-6.
126) Wyburn-Mason
(1983).
127) Perry
Chapdelaine, a science fiction writer and colleague of Isaac Asimov and A.E.
Van Vogt, later wrote non-fiction books and articles for the Arthritis Trust
under the pseudonym Anthony di Fabio (his birth name). The decades-long
association between Dr. Prosch and Chapdelaine/di Fabio, late founder of the
Arthritis Trust of America, was documented in The Townsend Letter, Aug-Sept,
2005. Online at www.arthritistrust.org/Articles/InMemoriamProsch.pdf.
128) Dr. Joseph
Mercola has achieved the same high cure rate following Dr. Brown's antibiotic
treatment protocol for mycoplasmal infection. He first recommends attention to
nutrition and allergies, as well as emotional and environmental factors, before
introducing any medications.
129) Clotrimazole is
an antifungal medication usually prescribed in low doses to treat Amoebiasis
and Tricomonas Vaginitis.
130) www.arthritistrust.org/history.htm
131) http://heartdisease.about.com/library/weekly/aa010101b.htm
(2000)
132) See www.bloodbook.com
for details on a variety of blood disorders.
133) Dr. Edwin A.
Deitch, MD. “Role of the Gut in Multiple Organ Dysfunction Syndrome.” Online at
www.theuniversityhospital.com/trauma/gut.htm
(2004)
134) www.ncbi.nlm.nih.gov/pubmed/20156361
(2010)
135) Bacteria
associated with many forms of arthritis are shown at http://www.thearthritiscenter.com/arthritis_info.htm
136) Nicolson, G.L.,
Nasralla, M.Y., Haier, J., Erwin, R., Nicolson, N.L., and Ngwenya, R.
“Mycoplasmal Infections in Chronic Illnesses: Fibromyalgia and Chronic Fatigue
Syndromes, Gulf War Illness, HIV-AIDS and Rheumatoid Arthritis.” Medical Sentinel 4:172-176, 1999.
137) Melbourne Forensic Diagnostic Services. “Sensitive Method for the Quantitative Detection of Mycoplasma Infections
and Its Relevance to Disease. ” Technical Newsletter #2. 1999.
138) Baseman and
Tully, at www.cdc.gov/ncidod/EID/vol3no1/baseman.htm
139) An example is
the 1993 docudrama/teleplay by Arnold Schulman based on the best-selling 1987
non-fiction book And the Band Played On: Politics, People, and the AIDS
Epidemic by the late Randy Shilts.
140)
For an excellent account of the politicization of the HIV
epidemic, see Garrett (1995) chapter 14.
141) Funding
comparisons at http://report.nih.gov/rcdc/categories/default.aspx
(2007-2011)
142) Piret J,
Desormeaux A, Bergeron MG. “Sodium Lauryl Sulfate, a Microbicide Effective
Against Enveloped and Nonenveloped Viruses.” Current Drug Targets,
Volume 3, Number 1, February 2002, pp. 17-30(14). Online at
www.ncbi.nlm.nih.gov/pubmed/11899262
143) Dr. CS Dayrit.
“Coconut oil in health and disease: its and monolaurin's potential as cure for
HIV/AIDS.” Indian Coconut Journal, Cochin. Online at www.coconutresearchcenter.org/article10526.pdf
(2000)
144) Insights in this
section are based on an IFM presentation by Dr. Lyn Patrick, ND entitled
“Hepatitis B/C: The Quiet Epidemic.” April, 2011.
145) Geier DA, Geier
MR. “A case-control study of serious autoimmune adverse events following
hepatitis B immunization.” Autoimmunity. 2005 Jun;38(4):295-301. www.ncbi.nlm.nih.gov/pubmed/16206512
146) WHO. “Viral
hepatitis: Report by the Secretariat.” March 2010. Online at http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_15-en.pdf
147) Antonelli, A.,
et al. “Thyroid Cancer in Patients with Hepatitis C Infection.” JAMA. 1999;281(17):1588. Online at http://jama.ama-assn.org/content/281/17/1588.1
148) www.cdc.gov/hepatitis/Statistics.htm
149) Los Angeles
Times, November 8, 2010.
150) Dr. Lyn Patrick,
op cit.
151) www.cdc.gov/hepatitis/hcv/hcvfaq.htm
(2011)
152) A useful
discussion forum is www.hepcchallenge.org
153) http://www.ra-infection-connection.com/Free_Articles/HowMuchVitC.htm
154) Jeannot E,
Boorman GA, et al. “Increased incidence of aflatoxin B1-induced liver tumors in
hepatitis virus C transgenic mice.” International journal of cancer.
ISSN: 0020-7136. 2011. Online at http://experts.kumc.edu/works/23192
155) USDA “Grain
Fungal Diseases & Mycotoxin Reference.” archive.gipsa.usda.gov/pubs/mycobook.pdf
(2006)
156) www.probiotic.org/bifidobacterium.htm
157) This is
according to each agency’s mission statement. See the home pages of the FDA and
the CDC on the Internet.
158) Associated Press
(unattributed). “Bad Blood Between FDA, Red Cross.” CBS/AP News online,
Washington, D.C., December 1, 2000. See www.cbsnews.com/now/story/0,1597,254190-412,00.shtml
159) http://blooddrivesafety.com/violations.htm (2011)
160) “Consumer
Advocate Urges Action on Blood-Supply Safety” (Reuters Health) December 2003.
161) www.redcrossblood.org/learn-about-blood/blood-facts-and-statistics
(2006)
162) Details at www.FDA.gov.
Enter “donor screening assay” in the search window. (2009)
163) Feldman, EA and
Bayer R. “Blood Safety in the Age of AIDS.” At www.bloodbook.com/safety-art.html
(11/2004)
164) [1]Sarkar S.
“Artificial blood.” Indian J Crit Care Med 2008;12:140-4. Online at http://www.ijccm.org/text.asp?2008/12/3/140/43685
165) http://science.howstuffworks.com/innovation/everyday-innovations/artificial-blood1.htm.
Also www.rsc.org/chemistryworld/Issues/2010/October/ArtificialBlood.asp
166) www.stemcellpioneers.com/showthread.php?p=14773
167) Kevin Deane, MD.
“Pneumococcal Vaccination in Patients With Rheumatic Diseases.” (2011) www.medscape.com/viewarticle/738426
168) http://virology-online.com/general/typesofvaccines.htm
169) Details at www.ra-infection-connection.com/OilNutrnRevln.htm
170) www.gatesfoundation.org/vaccines/Pages/default.aspx.
171) http://research.msu.edu/stories/researcher-develops-vaccine-strain-e-coli (2009)
172) Longbottom, D. “Chlamydial vaccine development.” J Med
Microbiol July 2003 vol. 52 no. 7 537-540; Levine MM, Kotloff KL, et al. “Clinical
trials of Shigella vaccines: two steps forward and one step back on a long,
hard road.” Nat Rev Microbiol. 2007 Jul;5(7):540-53; Atkins, HS,
Morton, M, et al. “Recombinant Salmonella vaccines for biodefence.” Vaccine
Volume 24, Issue 15, April 2006, pp. 2710-17; Prucca CG, Slavin I, et al.
“Antigenic variation in Giardia lamblia is regulated by RNA
interference.” Nature 456, 750-754 (11 Dec 2008) and Pechine S, Janoir C, et al. “Diminished
intestinal colonization by Clostridium difficile and immune response in
mice after mucosal immunization with surface proteins of C. difficile.” Vaccine.
May 2007.
173) Blaylock RL,
M.D..” The danger of excessive vaccination during brain development: the case
for a link to Autism Spectrum Disorders (ASD).” This 2008 article and all Dr.
Blaylock’s published papers and articles can be found on his website, www.russellblaylockmd.com.
174) Prandota J.
"Urinary Tract Diseases Revealed after DTP Vaccination in Infants and
Young Children." American Journal of Therapeutics. 2004;
11(5):344-353.
175) Pukhalsky AL, et
al. “Cytokine profile after rubella vaccine inoculation: evidence of the
immunosuppressive effect of vaccination.” Mediators Inflamm. 2003
August; 12(4): 203–207.
176) www.nvic.org/Myths-and-Facts.aspx
177) Presentation
“Controversies in Vaccinations” at the 2011 IFM International Symposium in
Bellevue, WA.